Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V4IH
|
|||
| Former ID |
DNC000400
|
|||
| Drug Name |
CEP1348
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mixed lineage kinase 2 (MAP3K10) | Target Info | Inhibitor | [1] |
| Panther Pathway | Huntington disease | |||
| p38 MAPK pathway | ||||
| Pathway Interaction Database | p38 MAPK signaling pathway | |||
| WikiPathways | Insulin Signaling | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.